About

Publications While At HealthPartners

selected publications

Journal Article

A Phase II randomized trial of panitumumab, erlotinib, and gemcitabine versus rrlotinib and hemcitabine in patients with nntreated, metastatic pancreatic adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance). 

The oncologist. 2019

North Central Cancer Treatment Group N0543 (Alliance): a phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma. 

Cancer. 2017

Contact

full name

J. P. Meyers

Quick Info

 

Collaboration

Co-author network

Map of science